Home » Topics » BioWorld Science

BioWorld Science
RSS

Janssen Pharmaceutica patents MGLL inhibitors

Oct. 18, 2021

Discovery of novel peptides that upregulate costimulatory and checkpoint pathways

Oct. 18, 2021

IEM presents new antiparkinsonian compounds

Oct. 18, 2021

PDAC priming boosts chemotherapeutic efficacy

Oct. 18, 2021

DeoBioSciences reports preclinical data on DBX-31 in advanced cancers

Oct. 15, 2021

NLS reports preclinical data on NLS-4 for long COVID

Oct. 15, 2021

Exelixis and Storm Therapeutics collaborate to advance novel drug leads for cancer

Oct. 15, 2021

Antidepressant treatment modulates inflammatory cytokine plasma levels in major depression

Oct. 15, 2021

Cell-free miRNAs as biomarkers of COVID-19 pneumonia and ARDS

Oct. 15, 2021

IL-36gamma-based therapy modulates immune response in pancreatic cancer models

Oct. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...